According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that China Resources Pharmaceutical Commercial Group Co., Ltd. (China Resources Pharmaceutical Commercial), a non-wholly-owned subsidiary of the company, obtained operating income of RMB 111,562 billion (same unit) for the six months ended June 30, 2026, an increase of 2.87% year on year; net profit attributable to owners of the parent company was 930 million yuan, an increase of 3.45% year on year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.